Neogen Chemicals Share Price

Specialty Chemicals company Neogen Chemicals announced Q4FY26 & FY26 results Consolidated Financial Highlights: Consolidated Revenue from operations for Q4FY26 was Rs 246.56 crore, representing a QoQ increase of 12.06% from Rs 220.02 crore in Q3FY26 and a YoY increase of 21.57% from Rs 202.82 crore in Q4FY25. For the full year FY26, consolidated Revenue from operations reached Rs 861.96 crore, showing a YoY growth of 10.85% compared to Rs 777.56 crore in FY25. Consolidated Total Income for Q4FY26 stood at Rs 247.54 crore, which is a QoQ increase of 11.45% from Rs 222.11 crore and a YoY increase of 21.69% from Rs 203.41 crore. Consolidated Net Profit for Q4FY26 was Rs 11.39 crore, reflecting a significant QoQ growth of 208.67% from Rs 3.69 crore and a YoY growth of 372.61% from Rs 2.41 crore in Q4FY25. For the full year FY26, consolidated Net Profit stood at Rs 28.75 crore, a YoY decline of 17.46% compared to Rs 34.83 crore in FY25. Standalone Financial Highlights: Standalone Revenue from operations for Q4FY26 was Rs 248.63 crore, up by 15.32% QoQ from Rs 215.60 crore in Q3FY26 and up by 22.03% YoY from Rs 203.75 crore in Q4FY25. For the full year FY26, standalone Revenue from operations was Rs 855.49 crore, registering a YoY increase of 10.58% from Rs 773.65 crore in FY25. Standalone Total Income for Q4FY26 stood at Rs 252.50 crore, representing a QoQ increase of 14.85% from Rs 219.86 crore and a YoY increase of 22.34% from Rs 206.40 crore. Standalone Net Profit for Q4FY26 was Rs 14.66 crore, marking a QoQ growth of 67.16% from Rs 8.77 crore and a YoY growth of 182.47% from Rs 5.19 crore. For the full year FY26, standalone Net Profit was Rs 46.96 crore, a slight YoY decline of 3.00% compared to Rs 48.41 crore in FY25. Business Highlights: Segment Performance: The company operates in a single reportable segment, which is Specialty Chemicals, in accordance with Ind AS 108. Dividend: The Board of Directors has recommended a final dividend of Rs 1 per equity share for the financial year FY26. Preferential Allotment: The company issued and allotted 10,00,000 equity shares at a price of Rs 1,610 per share (including a premium of Rs 1,600) to Cadamba Solutions Private Limited, a Promoter Group member, aggregating to Rs 161 crore. These shares were listed on the NSE and BSE on April 18, 2026. Neogen Ionics Limited (NIL) Project Updates: The wholly-owned subsidiary NIL has revised its project costs and timelines: The Dahej - Phase 1 project has a projected cost of Rs 428 crore with a revised SCOD of February 2027. The Pakhajan - Phase 2 project has a projected cost of Rs 1,367 crore with a revised SCOD of March 2027. The total projected cost for these initiatives is Rs 1,795 crore. Insurance Recovery: Following a fire incident at the Dahej SEZ Plant on March 5, 2025, the company received Rs 147.05 crore during the current year ended March 31, 2026. This amount includes Rs 140.00 crore as an on-account payment from the insurance company and Rs 7.05 crore from scrap sales. ESOP Grants: On February 11, 2026, the Nomination and Remuneration Committee approved the "Tranche - II Grant" of 50,200 ESOPs to 55 eligible employees at an exercise price of Rs 1,183.14 per option. Commenting on the Q4FY26 performance, Harin Kanani, Managing Director, Neogen Chemicals, said: “Demonstrating strong operational resilience, our Q4 & FY26 performance was robust against a challenging geopolitical backdrop. Growth was driven by high plant throughput and stable demand visibility across both our core and emerging applications. Input cost inflation, including packaging materials, remains mostly a pass-through for us, ensuring our core profitability remains protected. Underscoring our conviction in Neogen’s long-term growth trajectory and our strategic pivot into high-growth segments, the promoters have infused Rs 161 crore of capital to support our expansion plans. In Battery Materials, Neogen Ionics continues to strengthen its position as one of the most reliable player within India’s evolving lithium-ion battery materials ecosystem, that aligns with India’s ‘Atmanirbhar Bharat’ vision. The Pakhajan Greenfield Project timelines remain unchanged (H1 FY27 for Electrolyte and H2 FY27 for Electrolyte Salts) and the specialized MUIS Electrolyte plant has successfully initiated the trial-run phase to ensure process stabilization. Our immediate focus centers on phased capacity ramp-up and customer qualification. Encouragingly, for Electrolyte Salts, provisional approvals have already been received from additional international customers, and final site audits are actively underway to transition them to commercial-ready supplies. Looking ahead, FY27 is expected to be a transformative year for Neogen as we commission one of India’s largest greenfield facilities dedicated to Battery Materials at Pakhajan. Simultaneously, Neogen Ionics' Dahej plant also received 3 US-based electrolyte makers audit approval and will also scale up this year supported by improving demand visibility. Furthermore, our standalone operations are set to resume a normalized growth trajectory, aided by the replacement plant at Dahej expected to be commissioned by June 2026. Backed by these growth drivers, we remain confident of achieving revenues in the range of Rs 875– 950 crore in FY27, at standalone basis, considering MPP-5 full production from Q2 FY26.” Result PDF

• Trendlyne
• 2 weeks 3 days ago

Conference Call with Neogen Chemicals Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

• Trendlyne
• 3 months 2 weeks ago

Specialty Chemicals company Neogen Chemicals announced Q1FY26 results Revenues stood at Rs 187 crore, higher by 4% YoY. EBITDA for Q1FY26 is Rs 32 crore, higher by 2% YoY. EBITDA Margin stood at 16.9%. Profit after tax for Q1FY26 stood at Rs 10 crore. PAT largely mirrored operational performance. Earnings per share (EPS) for Q1FY26 stood at Rs 3.89 per share (Rs 4.35 per share in Q1FY25) not annualised. Haridas Kanani, Chairman & Managing Director, Neogen Chemicals said: "We delivered a resilient performance in Q1FY26, demonstrating the inherent strength of our diversified business model, even with our Dahej plant unavailable for the entire quarter due to the unfortunate fire. Volume-driven growth was propelled by our base business. Additionally, Neogen Ionics began contributing by initiating Commercial Sales in both Electrolyte and Lithium Electrolyte Salts. Despite the prevailing soft pricing environment, we effectively maintained our performance showcasing the strength and agility of our business model. Our strategic initiatives are moving forward with good momentum, as is our recovery from the fire incident. We have secured initial insurance claims and the rebuilding of our Dahej plant is progressing swiftly aiming for completion by next year. Concurrently, our greenfield facility at Pakhajan for Electrolyte and Lithium Salts is taking shape, with key milestones accomplished and vital equipment ordered. This project is a cornerstone of our future growth. Looking ahead, our vision for Neogen Chemicals remains ambitious and clearly defined. The proposed JV with Morita is a testament to our long-term strategy, firmly positioning us in the rapidly growing battery chemicals sector. While we have adjusted our near-term revenue guidance to reflect current operational realities, our long-term trajectory is robust. We are confidently building a stronger, more diversified Company, ready to capitalize on future opportunities.” Result PDF

• Trendlyne
• 10 months ago